Showing results (571-580 of 608) with videos related to

Sort By:
Pageof 61
Minerva Urology and Nephrology|August 2, 2023
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registriesAndrea Panunzio, Stefano Tappero, Mattia Piccinelli, et al.
Nature Cell Biology|June 27, 2018
Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathwayFrédéric Lessard, Sebastian Igelmann, Christian Trahan, et al.
International Journal for Parasitology|March 4, 2020
Vaccination against canine leishmaniasis in BrazilFilipe Dantas-Torres, Fábio Dos Santos Nogueira, Ingrid Menz, et al.
Nature Communications|April 23, 2024
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acidsGabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
European Journal of Endocrinology|November 4, 2011
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patientsMaria Candida B V Fragoso, Madson Queiroz Almeida, Tania L Mazzuco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2014
ARMC5 mutations are a frequent cause of primary macronodular adrenal HyperplasiaGuilherme Asmar Alencar, Antonio Marcondes Lerario, Mirian Yumie Nishi, et al.
Function (Oxford, England)|February 13, 2023
Comparing Transgenic Production to Supplementation of ω-3 PUFA Reveals Distinct But Overlapping Mechanisms Underlying Protection Against Metabolic and Hepatic DisordersNoëmie Daniel, Mélanie Le Barz, Patricia L Mitchell, et al.
Journal of Medical Genetics|December 14, 2004
A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesionsK J Griffin, L S Kirschner, L Matyakhina, et al.
Pain|March 3, 2022
A follow-up of pain reported by children undergoing outpatient surgery using a smartphone application: AlgoDARPEF multicenter descriptive prospective studyYannick Walrave, Michel Carles, Jean-Noel Evain, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2018
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2Mario Campone, Seock-Ah Im, Hiroji Iwata, et al.
Pageof 61